Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 465, pseudogene (RNU6-465P)
- Target
- RNU6-465P
- Molecular classification
- Pseudogene, Non-coding RNA (ncRNA), U6 small nuclear RNA (snRNA)–derived sequence
01
Overview
**RNA, U6 small nuclear 465, pseudogene (RNU6-465P)** is a non-coding RNA classified as a pseudogene derived from the highly conserved U6 small nuclear RNA sequence family[4][5]. U6 snRNA is a critical part of the spliceosome, which catalyzes the removal of introns from pre-mRNA in eukaryotes; however, RNU6-465P itself is a processed pseudogene and does not encode a functional RNA product or protein[1][3][5]. Pseudogenes like RNU6-465P arise from retrotransposition or duplication events and generally do not possess biological function, though they serve as genomic evidence of historical gene duplication or retrotranspositional activity[5]. There are no known drug interactions, disease associations, or therapeutic applications for RNU6-465P, and it is not considered a therapeutic or biological target[4][5].
- Other names
- RNU6-465P
02
Biological functions
Other (not biologically functional, as it is a pseudogene)
03
Disease associations
Other (no direct evidence of involvement in disease; U6 pseudogenes may occasionally serve as markers for retrotransposition or genomic studies[5])
Beyond the preview
Go deeper on RNA, U6 small nuclear 465, pseudogene (RNU6-465P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 465, pseudogene (RNU6-465P).